Christos Koros

2.0k total citations
64 papers, 1.1k citations indexed

About

Christos Koros is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Christos Koros has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Physiology. Recurrent topics in Christos Koros's work include Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (16 papers) and Lysosomal Storage Disorders Research (9 papers). Christos Koros is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (16 papers) and Lysosomal Storage Disorders Research (9 papers). Christos Koros collaborates with scholars based in Greece, Germany and United States. Christos Koros's co-authors include Leonidas Stefanis, Athina Maria Simitsi, María Stamelou, Nikolaos Papagiannakis, Anastasia Bougea, Efthimia Kitraki, Matina Maniati, Dimitra Papadimitriou, Sokratis G. Papageorgiou and Roubina Antonelou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Christos Koros

61 papers receiving 1.1k citations

Peers

Countries citing papers authored by Christos Koros

Since Specialization

Citations

This map shows the geographic impact of Christos Koros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Koros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Koros more than expected).

Fields of papers citing papers by Christos Koros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos Koros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Koros. The network helps show where Christos Koros may publish in the future.

Co-authorship network of co-authors of Christos Koros

This figure shows the co-authorship network connecting the top 25 collaborators of Christos Koros. A scholar is included among the top collaborators of Christos Koros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos Koros. Christos Koros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An In-Person and Online Intervention for Parkinson Disease (UPGRADE-PD): Protocol for a Patient-Centered and Culturally Tailored 3-Arm Crossover Trial 2025 ·JMIR Research Protocols ·(unknown), Irene Grimani, Μarianna Papadopoulou, Nikolaos Papagiannakis, Anastasia Bougea, (unknown), (unknown), (unknown), (unknown), Roubina Antonelou, Christos Koros, (unknown), (unknown), Leonidas Stefanis, (unknown)	2
2	Development of a Specialized Telemedicine Protocol for Cognitive Disorders: The TeleCogNition Project in Greece 2025 ·Geriatrics ·Efthalia Angelopoulou, (unknown), (unknown), (unknown), (unknown), Dionysia Kontaxopoulou, Christos Koros, John Papatriantafyllou, Vasiliki Zilidou, (unknown), (unknown), Paraskevi Sakka, Haralampos Karanikas, Leonidas Stefanis, Panagiotis D. Bamidis, Sokratis G. Papageorgiou	0
3	Neurofilament Biomarkers in Neurology: From Neuroinflammation to Neurodegeneration, Bridging Established and Novel Analytical Advances with Clinical Practice 2025 ·International Journal of Molecular Sciences ·(unknown), Christos Koros, (unknown), (unknown), Michail Rentzos, Sokratis G. Papageorgiou, Maria Anagnostouli	0
4	Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin‐Related Parkinson's Disease 2024 ·Movement Disorders ·Nikolaos Papagiannakis, (unknown), Christos Koros, (unknown), María Stamelou, Matina Maniati, Elena Buena‐Atienza, (unknown), Georgia Karadima, Periklis Makrythanasis, Giannis Vatsellas, Enza Maria Valente, Thomas Gasser, Leonidas Stefanis	3
5	The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review 2023 ·Genes ·Christos Koros, Anastasia Bougea, Athina Maria Simitsi, Nikolaos Papagiannakis, Efthalia Angelopoulou, (unknown), Roubina Antonelou, Maria Bozi, María Stamelou, Leonidas Stefanis	9
6	Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review 2023 ·Medicina ·Efthalia Angelopoulou, (unknown), (unknown), Anastasia Bougea, Dionysia Kontaxopoulou, (unknown), Christos Koros, Vasiliki Georgakopoulou, George Fotakopoulos, Yiannis Koutedakis, Christina Piperi, Sokratis G. Papageorgiou	19
7	Perceptions of Patients, Caregivers, and Healthcare Professionals toward Telemedicine Use for Cognitive and Movement Disorders in the Aegean Islands, Greece: A Pilot Study of the SI4CARE European Project 2023 ·Geriatrics ·Efthalia Angelopoulou, Dionysia Kontaxopoulou, (unknown), (unknown), (unknown), John Papatriantafyllou, Christos Koros, Vlado Dimovski, (unknown), Sokratis G. Papageorgiou	3
8	Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study 2023 ·Journal of Parkinson s Disease ·Christos Koros, (unknown), Nikolaos Papagiannakis, Anastasia Bougea, (unknown), Dimitra Papadimitriou, (unknown), Ion Beratis, (unknown), Efthalia Angelopoulou, Roubina Antonelou, (unknown), (unknown), Sokratis G. Papageorgiou, Anastasios Bonakis, (unknown), María Stamelou, Leonidas Stefanis	9
9	Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease 2023 ·Journal of Parkinson s Disease ·(unknown), (unknown), Christos Koros, Athina Maria Simitsi, Anastasia Bougea, Maria Bozi, Nikolaos Papagiannakis, (unknown), (unknown), (unknown), Nikolaos Scarmeas, George P. Paraskevas, Konstantinos Voumvourakis, Sokratis G. Papageorgiou, Konstantinos Kollias, Nikos C. Stefanis, Leonidas Stefanis	4
10	Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It? 2023 ·Medicina ·(unknown), Dimitrios Kasselimis, (unknown), Anastasia Bougea, Christos Koros, Athina Maria Simitsi, Leonidas Stefanis, Constantin Potagas	1
11	Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia 2023 ·Diagnostics ·Vasilios C. Constantinides, Fotini Boufidou, Mara Bourbouli, (unknown), (unknown), Christos Koros, (unknown), Sokratis G. Papageorgiou, Leonidas Stefanis, George P. Paraskevas, Elisabeth Kapaki	4
12	Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers 2021 ·Parkinsonism & Related Disorders ·(unknown), Christos Koros, Athina Maria Simitsi, Dimitra Papadimitriou, Anastasia Bougea, (unknown), Nikolaos Papagiannakis, Maria Bozi, Roubina Antonelou, Efthalia Angelopoulou, Ion Beratis, María Stamelou, (unknown), Sokratis G. Papageorgiou, Leonidas Stefanis	7
13	Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients 2020 ·Annals of Clinical and Translational Neurology ·Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, Christos Koros, Athina Maria Simitsi, (unknown), Marianthi Breza, Leonidas Stefanis, Epaminondas Doxakis	42
14	Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review 2020 ·Complementary Therapies in Clinical Practice ·Anastasia Bougea, Christos Koros, (unknown), (unknown), (unknown), Leonidas Stefanis	19
15	Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease 2019 ·Movement Disorders ·Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, Matina Maniati, Christos Koros, (unknown), Maria Bozi, (unknown), María Stamelou, George P. Paraskevas, Elisabeth Kapaki, Marina Moraitou, Helen Michelakakis, Leonidas Stefanis, Epaminondas Doxakis	44
16	Salivary alpha-synuclein as a biomarker for Parkinson’s disease: a systematic review 2019 ·Journal of Neural Transmission ·Anastasia Bougea, Christos Koros, Leonidas Stefanis	39
17	Genetics of Parkinson's Disease 2017 ·International review of neurobiology ·Christos Koros, Athina Maria Simitsi, Leonidas Stefanis	65
18	A Selective Memory Deficit Caused by Autoimmune Encephalopathy Associated With Hashimoto Thyroiditis 2012 ·Cognitive and Behavioral Neurology ·Christos Koros, Alexandra Economou, George Mastorakos, Anastasios Bonakis, Nikolaos Kalfakis, Sokratis G. Papageorgiou	6
19	Rapidly Progressive Dementia - Clinical Aspects and Management 2011 ·European Neurological Review ·Sokratis G. Papageorgiou, Christos Koros, (unknown)	2
20	Neurofilament isoform alterations in the rat cerebellum following cytosine arabinoside administration 2009 ·Toxicology Letters ·Christos Koros, Efthimia Kitraki	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact